Tag: Early
Takeda offers Japanese sales, admin staffers early retirement in post-Shire slimdown
The ax has fallen on Takeda’s home business in Japan as part of a companywide restructuring triggered by its $59 billion Shire acquisition.
Takeda is...
Pfizer, BioNTech coronavirus vaccine candidate gins up antibodies in early trial
With the eyes of the world turned on the global COVID-19 vaccine race, Pfizer and its partner BioNTech posted early positive data from one of their...
Roche’s Kadcyla wins NICE backing in early breast cancer use
Unlike its first U.K. reimbursement negotiations, Roche’s HER2 antibody-drug conjugate sailed through a new NHS funding review that now puts it in line for...
Early missteps, transparency questions dog U.S. government’s remdesivir rollout: reports
When there’s only one proven therapy for a global pandemic that’s infected millions—and a limited initial supply—how exactly should officials distribute it? So far, the U.S. government...
